PipelinePharma Logo
PipelinePharma Logo

CTD Dossier Marketplace

Direct connection with CTD dossier (IP) owners and manufacturers

Marketing Authorizations Database

Search across marketing authorization registers
Sign in Get started

Generics

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Biosimilars for sale

Filters

follitropin alfa

Solution for injection 900 IU/1,08 mL

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
France , Germany , Italy , Spain , United Kingdom
Available for
Distribution only
Manufacturer #17281
This company has improved the lives of millions of women all around the world. They are still working on patient-centered, effective solutions to help women of all ages. It collaborates closely with partners, healthcare experts, and patients to give the best solution for women at the right time.

Manufacturer usually replies in 5 days

ustekinumab

Injection 45 mg, 90 mg, 130 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP, MHRA, Canada, Switzerland
Unavailable markets
Belgium , Canada , Czech Republic , Denmark , Finland , France , Germany , Italy , Jordan , Kuwait , Norway , Saudi Arabia , Slovakia , South Africa , Spain , United Arab Emirates , United Kingdom , United States
Comments
Ref. Stelara
Manufacturer #38577

The company is a pharmaceutical manufacturer operating as a biopharmaceutical and biotech specialist focused on the development of high-quality biosimilars, meaning follow-on versions of biopharmaceutical medicines, with activities spanning technical pharmaceutical development, clinical trials and regulatory approval to develop and support the commercialization of these pharmaceutical products across regulated global markets.

Manufacturer usually replies in 10 days

the only CTD on the platform

aflibercept intravitreal

Injection 40 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP
Unavailable markets
Algeria , Egypt , Kuwait , Liberia , Oman , Qatar , Saudi Arabia , Tunisia , United Arab Emirates , Yemen
Comments
Ref. Eylea®
Manufacturer #38577

The company is a pharmaceutical manufacturer operating as a biopharmaceutical and biotech specialist focused on the development of high-quality biosimilars, meaning follow-on versions of biopharmaceutical medicines, with activities spanning technical pharmaceutical development, clinical trials and regulatory approval to develop and support the commercialization of these pharmaceutical products across regulated global markets.

Manufacturer usually replies in 10 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.